Investing Profile

Jill carroll

Photo of Jill carroll, Principal at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Duke University Network
51 CONNECTIONS
cb
SR One Principal
2
CompanyStageDateRound SizeTotal Raised
Tioma Therapeutics
Series AAug 2016$86M
$86M
Co-investors: Carole Nuechterlein (Roche Venture Fund)
Applied Genetics Technologies Corporation
Series BNov 2012$37.5M
$37.5M
Principal S.R. One Ltd2011 - Present
VP, Corporate Development Limerick Biopharma2010 - 2011
Sr Director, Strategic Planning & Corporate Development Dynavax Technologies2004 - 2010
Director, Market Analysis Clearview Projects2001 - 2004
Consultant Mercer Management Consulting1999 - 2001
Johns Hopkins University MS Biochemistry
Duke University BS Chemistry